The University of Alberta is recruiting postdoctoral scholars outside Canada, including Canadians currently working or studying abroad, under the one-time Canada Impact + Research Training Awards Initiative.
This initiative aims to attract talented researchers to Canada to strengthen the country’s research ecosystem in priority areas.
The program will offer 400 post-doctoral research awards at $70,000/year for up to two years. The fellowships are administered by Social Sciences and Humanities Research Council (SSHRC), the Canadian Institutes of Health Research (CIHR), and the Natural Sciences and Engineering Research Council of Canada (NSERC).
Priority Research Areas
The candidate’s research must align with one of the following priority areas:
- Advanced digital technologies (AI, quantum, cybersecurity)
- Health, including biotechnology
- Clean technology and resource value chains
- Environment, climate resilience, and the Arctic
- Food and water security
- Democratic and community resilience
- Manufacturing and advanced materials
- Defence and dual-use technologies
Eligibility
Applicants must meet all of the following conditions:
- Can hold any citizenship
- Must not currently be affiliated with a Canadian institution
- Must be working or studying outside Canada
- Canadian citizens must return after gaining research/work experience abroad
- Must be ready to undertake research in Canada by March 31, 2027
- Must hold or expect to hold a doctoral or health professional degree before the start date
Application Process
Prospective postdoctoral scholars must first contact a faculty member at the University of Alberta willing to act as a supervisor. The Faculty member (nominator) is to complete the Expression of Interest (EOI) Form for the prospective doctoral student.
The nominator and nominee jointly select CIHR, NSERC, or SSHRC based on research alignment.
GPS will review EOI Forms. Those selected will be invited to put together a full application/nomination package to be submitted by the institution for the March 4 deadline.
Important Deadlines
| Deadline for faculty nominators to submit EOI to GPS | February 9, 2026 |
| Institutional deadline to submit nominations to Tri-Council | March 4, 2026 |
I would appreciate if I was considered
I will quite appreciate if granted opportunity to participate in the University of Alberta Postdoc Fellowship 2026 under Canada Impact+ Research Training Awards”. I am just a fresher from attainment of my PhD in Banking and Finance in 2025 and would be glad to participate in the programme as I hope to come back to my country to bear whatever I may have leant on solving solving done of the socio-economic challenges of my country, Nigeria.
Thanks
Uloghobui Z.M. PhD
Subject: Kindly look into my hypothesis for any kind of work with your teams
Sir,
Greetings
I have seen about the notification for research at University of Alberta. .I wish my hypothesis given hereunder acclaimed as ” Important studies worth experimenting” by Dr.George Klein of Tumour Biology, Karolinska Instt, Stockholm way back in 1984, may also help DMD as AOC( Antibody- Oliginucleotide- Conjugate) is being a therapeutic and besides cancer( leukaemias and lymphomas in particular) and HIV/ AIDS.You may help organise a team to work out my hypothesis.I an now 70 and not in good health but may coordinate with the working team on line.Please help me out.
I participated in 5th Int’l Congress of Immunology, Aug.1983, Kyoto, Japan having stayed over night in Tokyo and visited Tokyo Medical Research Institute.You may help me have my hypothesis given below experimented over there by any suitable team to help humanity.
This is my update.As you will patiently go through the following you will find mev as a budding MBBS Pathology medico from India around 1977-78, I was beseiged by the Lyon hypothesis through TB of Pathology by Sir William Boyd, p 504 or 508 if remember correctly that some female tumour cells had otherwise inert barr body got into intranuclear milieu instead of being at the nuclear membrane and thus participating in the intranuclear milieu.I got into postulate H- X Chr( Histcompatibility X Chromosomal) gene and it as an abstract was accepted for 6th Int’l Congress of Human Genetics, Sept 1981, Jerusalem and next in 7th Int’l Cong.Of Human Genetics, Sept 1986, Berlin but I could not attend either .I delved into its ramifications on the postulate of Immunoglobulin( Ig L 1) in Tumor cells, especially in leukemias like in Burkit’s lymphoma having the C- myc oncogene participation, I postulated the participation of aviation origin onc gene, c- myb( myeloblastosis) in Ig variable gene( v) translocations of t( 6;14)/( 6; 2)/(6;22) ie., 6 denotes c-myb locus( like 8 for c-myc in Burkitts) while 14 stands for variable heavy chain gene and 2 and 22 stand for variable light chain genes respectively) and I conceived that this v’ gene rearrangement following translications may lead to immunoglobulin Ig L1 specificity or Leukemia or lymphoma specificity or anti- leukemia antibody specificity( ALAB) and the respective m- RNA may be used in templates like e coli organism to abundantly manufacture the synthetic Ig L1 or ALAB for immunotherapy against Cancer, leukemias and AIDS since it has molecular relation through H- TLV-Iii( human T- cell leukemia/ lymphoma Virus).I last attended HIV Congress 2008, Mumbai, India in March ’08.
Dr.George Klein, Head of Tumour Biology Unit of Karolinska Instt., Stockholm in 1984 appreciated it as important studies worth experimenting and Dr.Avery A.Sandberg of Genetics& Cytogenetics Journal of USA had earlier called it a provocative hypothesis but I have not yet got a God father or Mentor like Ramanuhan got one in G.H. Hardy to bring him to Cambridge to work on.I am now 70( I attended 5th Int’l Cong of Immunology, Aug 1983, Kyoto, Japan in W-101 session and met Hugh O DeWitt of Stanford, E.S.Lennox of UK and others).I wish I may have my hypothesis experimented by some teams worldover( I may co-work with them on line or on a Sabbattical ) and Cambridge MRC lab may be ideal. The following gives you my related communication with others and can give you my quest to have my hypothesis published so that some team will take it up experimenting and I do hope it will help humanity.Even after 41 years since Dr.Klein encouraged me that if I get a Fellowship he may give me a place to work, besides also Dr.Klaus Eichmann of Maxplanck Inst of Immunobiology, Frieburg, Germany whi also said that if I’d get a Fellowship he’d try to offer place to work.
Regards
Dr.T.Ramadas
India
[email protected]
Show trimmed content
Hide trimmed content